Advanced Wound Care and Regenerative Medicine Access and Reform Act

This bill establishes a new payment system for skin substitute products (materials applied to wounds that remain within the wound bed) under Medicare, setting specific payment amounts and annual updates based on inflation. It requires the creation of a new billing code for these products by January 2026, ensures equal reimbursement regardless of where treatment occurs, and creates oversight for providers with unusually high payments. The bill also directs the FDA to review and potentially streamline approval processes for human tissue-based regenerative medicine products. These changes aim to improve access to advanced wound care while maintaining proper oversight of Medicare payments.